Table of Contents Author Guidelines Submit a Manuscript
Journal of Tropical Medicine
Volume 2017, Article ID 2189814, 7 pages
https://doi.org/10.1155/2017/2189814
Review Article

Discovery of Antimalarial Drugs from Streptomycetes Metabolites Using a Metabolomic Approach

1Programme of Biomedical Science, School of Diagnostic and Applied Health Sciences, Faculty of Health Science, Universiti Kebangsaan Malaysia (UKM), 50300 Kuala Lumpur, Malaysia
2Institute of Systems Biology (INBIOSIS), Universiti Kebangsaan Malaysia, 43600 UKM Bangi, Selangor, Malaysia
3Department of Biomedical Science, Kulliyyah of Allied Health Sciences, International Islamic University Malaysia, Jalan Sultan Ahmad Shah, 25200 Kuantan, Pahang, Malaysia

Correspondence should be addressed to Noraziah Mohamad Zin; ym.ude.mku@niz.haizaron

Received 28 July 2017; Accepted 30 August 2017; Published 16 October 2017

Academic Editor: Jean-Paul J. Gonzalez

Copyright © 2017 Siti Junaidah Ahmad et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Lahlou, “Screening of natural products for drug discovery,” Expert Opinion on Drug Discovery, vol. 2, no. 5, pp. 697–705, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. D. J. Newman, G. M. Cragg, and K. M. Snader, “The influence of natural products upon drug discovery,” Natural Product Reports, vol. 17, no. 3, pp. 215–234, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Smaoui, F. Mathieu, L. Elleuch et al., “Taxonomy, purification and chemical characterization of four bioactive compounds from new Streptomyces sp. TN256 strain,” World Journal of Microbiology and Biotechnology, vol. 28, no. 3, pp. 793–804, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Van Middlesworth and R. J. Cannell, “Dereplication and partial identification of natural products,” in Natural Products Isolation, R. J. P. Cannell, Ed., vol. 4 of Methods in Biotechnology, pp. 279–327, Humana Press, Totowa, NJ, USA, 1998. View at Publisher · View at Google Scholar
  5. T. Ito and M. Masubuchi, “Dereplication of microbial extracts and related analytical technologies,” Journal of Antibiotics, vol. 67, no. 5, pp. 353–360, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Carnevale Neto, A. C. Pilon, D. M. Selegato et al., “Dereplication of natural products using GC-TOF mass spectrometry: improved metabolite identification by spectral deconvolution ratio analysis,” Frontiers in Molecular Biosciences, vol. 3, no. 2, 2016. View at Publisher · View at Google Scholar
  7. L. Dinan, “Dereplication and partial identification of compounds,” in Natural Products Isolation, S. D. Sarker, Z. Latif, and A. I. Gray, Eds., pp. 297–321, Humana Press, Totowa, NJ, USA, 2005. View at Google Scholar
  8. A. L. Harvey, R. Edrada-Ebel, and R. J. Quinn, “The re-emergence of natural products for drug discovery in the genomics era,” Nature Reviews Drug Discovery, vol. 14, no. 2, pp. 111–129, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. A. F. Tawfike, C. Viegelmann, and R. Edrada-Ebel, “Metabolomics and dereplication strategies in natural products,” Methods in Molecular Biology, vol. 1055, pp. 227–244, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Rochfort, “Metabolomics reviewed: A new "omics" platform technology for systems biology and implications for natural products research,” Journal of Natural Products, vol. 68, no. 12, pp. 1813–1820, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. D. S. Wishart, “Applications of metabolomics in drug discovery and development,” Drugs in R and D, vol. 9, no. 5, pp. 307–322, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. A. L. Demain, “Microbial production of primary metabolites,” Naturwissenschaften, vol. 67, no. 12, pp. 582–587, 1980. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Bérdy, “Bioactive microbial metabolites,” The Journal of Antibiotics, vol. 58, no. 1, pp. 1–26, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Bourgaud, A. Gravot, S. Milesi, and E. Gontier, “Production of plant secondary metabolites: a historical perspective,” Plant Science, vol. 161, no. 5, pp. 839–851, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. Q.-T. Nguyen, M. E. Merlo, M. H. Medema, A. Jankevics, R. Breitling, and E. Takano, “Metabolomics methods for the synthetic biology of secondary metabolism,” FEBS Letters, vol. 586, no. 15, pp. 2177–2183, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. N. I. M. Sarmin, G. Y. A. Tan, C. M. M. Franco, R. Edrada-Ebel, J. Latip, and N. M. Zin, “Streptomyces kebangsaanensis sp. nov., an endophytic actinomycete isolated from an ethnomedicinal plant, which produces phenazine-1-carboxylic acid,” International Journal of Systematic and Evolutionary Microbiology, vol. 63, no. 10, pp. 3733–3738, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. S. T. Williams, M. Goodfellow, G. Alderson, E. M. Wellington, P. H. Sneath, and M. J. Sackin, “Numerical Classification of Streptomyces and Related Genera,” Microbiology, vol. 129, no. 6, pp. 1743–1813, 1983. View at Publisher · View at Google Scholar
  18. D. J. Newman and G. M. Cragg, “Natural products as sources of new drugs over the last 25 years,” Journal of Natural Products, vol. 70, no. 3, pp. 461–477, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Nett, H. Ikeda, and B. S. Moore, “Genomic basis for natural product biosynthetic diversity in the actinomycetes,” Natural Product Reports, vol. 26, no. 11, pp. 1362–1384, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. R. P. Maskey, E. Helmke, O. Kayser et al., “Anti-cancer and antibacterial trioxacarcins with high anti-malaria activity from a marine streptomycete and their absolute stereochemistry,” Journal of Antibiotics, vol. 57, no. 12, pp. 771–779, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Ezra, U. F. Castillo, G. A. Strobel et al., “Coronamycins, peptide antibiotics produced by a verticillate Streptomyces sp. (MSU-2110) endophytic on Monstera sp,” Microbiology, vol. 150, no. 4, pp. 785–793, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. U. F. Castillo, G. A. Strobel, K. Mullenberg et al., “Munumbicins E-4 and E-5: Novel broad-spectrum antibiotics from Streptomyces NRRL 3052,” FEMS Microbiology Letters, vol. 255, no. 2, pp. 296–300, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. U. F. Castillo, G. A. Strobel, E. J. Ford et al., “Munumbicins, wide-spectrum antibiotics produced by Streptomyces NRRL 30562, endophytic on Kennedia nigriscans,” Microbiology, vol. 148, no. 9, pp. 2675–2685, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Isaka, A. Jaturapat, J. Kramyu, M. Tanticharoen, and Y. Thebtaranonth, “Potent in vitro antimalarial activity of metacycloprodigiosin isolated from Streptomyces spectabilis BCC 4785,” Antimicrobial Agents and Chemotherapy, vol. 46, no. 4, pp. 1112-1113, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. U. Castillo, J. K. Harper, G. A. Strobel et al., “Kakadumycins, novel antibiotics from Streptomyces sp. NRRL 30566, an endophyte of Grevillea pteridifolia,” FEMS Microbiology Letters, vol. 224, no. 2, pp. 183–190, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. N. M. Zin, M. S. Baba, A. H. Zainal-Abidin, J. Latip, N. W. Mazlan, and R. Edrada-Ebel, “Gancidin W, a potential low-toxicity antimalarial agent isolated from an endophytic Streptomyces SUK10,” Drug Design, Development and Therapy, vol. 11, pp. 351–363, 2017. View at Publisher · View at Google Scholar · View at Scopus
  27. L.-L. Yan, N.-N. Han, Y.-Q. Zhang et al., “Antimycin A18 produced by an endophytic Streptomyces albidoflavus isolated from a mangrove plant,” The Journal of Antibiotics, vol. 63, no. 5, pp. 259–261, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Li, C. Lu, and Y. Shen, “Macrolides of the bafilomycin family produced by Streptomyces sp. CS,” Journal of Antibiotics, vol. 63, no. 10, pp. 595–599, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. F. Tomita, T. Tamaoki, M. Morimoto, and K. Fujimoto, “Trioxacarcins, novel antitumor antibiotics. I. Producing organism, fermentation and biological activities,” Journal of Antibiotics, vol. 34, no. 12, pp. 1519–1524, 1981. View at Publisher · View at Google Scholar · View at Scopus
  30. G. Strobel, B. Daisy, U. Castillo, and J. Harper, “Natural products from endophytic microorganisms,” Journal of Natural Products, vol. 67, no. 2, pp. 257–268, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. L. K. Basco, E. Heseltine, and W. H. Organization, Field application of in vitro assays for the sensitivity of human malaria parasites to antimalarial drugs, 2007.
  32. H. Noedl, C. Wongsrichanalai, and W. H. Wernsdorfer, “Malaria drug-sensitivity testing: New assays, new perspectives,” Trends in Parasitology, vol. 19, no. 4, pp. 175–181, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. W. Trager and J. B. Jensen, “Human malaria parasites in continuous culture,” Science, vol. 193, no. 4254, pp. 673–675, 1976. View at Publisher · View at Google Scholar · View at Scopus
  34. L. K. Basco, F. Marquet, M. M. Makler, and J. Lebras, “Plasmodium falciparum and Plasmodium vivax: Lactate-Dehydrogenase Activity and Its Application for in Vitro Drug Susceptibility Assay,” Experimental Parasitology, vol. 80, no. 2, pp. 260–271, 1995. View at Publisher · View at Google Scholar · View at Scopus
  35. R. J. Howard, S. Uni, M. Aikawa et al., “Secretion of a malarial histidine-rich protein (Pf HRP II) from Plasmodium falciparum-infected erythrocytes,” Journal of Cell Biology, vol. 103, no. 4, pp. 1269–1277, 1986. View at Publisher · View at Google Scholar · View at Scopus
  36. V. Desakorn, K. Silamut, B. Angus et al., “Semi-quantitative measurement of Plasmodium falciparum antigen PfHRP2 in blood and plasma,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 91, no. 4, pp. 479–483, 1997. View at Publisher · View at Google Scholar · View at Scopus
  37. A. V. Pandey, H. Bisht, V. K. Babbarwal, J. Srivastava, K. C. Pandey, and V. S. Chauhan, “Mechanism of malarial haem detoxification inhibition by chloroquine,” Biochemical Journal, vol. 355, no. 2, pp. 333–338, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. T. E. Wellems and R. J. Howard, “Homologous genes encode two distinct histidine-rich proteins in a cloned isolate of Plasmodium falciparum.,” Proceedings of the National Academy of Sciences, vol. 83, no. 16, pp. 6065–6069, 1986. View at Publisher · View at Google Scholar
  39. D. E. Goldberg, A. F. Slater, A. Cerami, and G. B. Henderson, “Hemoglobin degradation in the malaria parasite Plasmodium falciparum: an ordered process in a unique organelle.,” Proceedings of the National Academy of Sciences, vol. 87, no. 8, pp. 2931–2935, 1990. View at Publisher · View at Google Scholar
  40. S. R. Meshnick, “Is haemozoin a target for antimalarial drugs?” Annals of Tropical Medicine & Parasitology, vol. 90, no. 4, pp. 367–372, 2016. View at Publisher · View at Google Scholar
  41. A. F. G. Slater and A. Cerami, “Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites,” Nature, vol. 355, no. 6356, pp. 167–169, 1992. View at Publisher · View at Google Scholar · View at Scopus
  42. V. Desakorn, A. M. Dondorp, K. Silamut et al., “Stage-dependent production and release of histidine-rich protein 2 by Plasmodium falciparum,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 99, no. 7, pp. 517–524, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Houzé, M. D. Boly, J. Le Bras, P. Deloron, and J.-F. Faucher, “PfHRP2 and PfLDH antigen detection for monitoring the efficacy of artemisinin-based combination therapy (ACT) in the treatment of uncomplicated falciparum malaria,” Malaria Journal, vol. 8, no. 1, article no. 211, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. H. Noedl, B. Attlmayr, W. H. Wernsdorfer, H. Kollaritsch, and R. S. Miller, “A histidine-rich protein 2-based malaria drug sensitivity assay for field use,” American Journal of Tropical Medicine and Hygiene, vol. 71, no. 6, pp. 711–714, 2004. View at Google Scholar · View at Scopus
  45. D. J. Hinrichs and M. T. Makler, “Measurement of the lactate dehydrogenase activity of plasmodium falciparum as an assessment of parasitemia,” The American Journal of Tropical Medicine and Hygiene, vol. 48, no. 2, pp. 205–210, 1993. View at Publisher · View at Google Scholar
  46. M. T. Makler, C. J. Palmer, and A. L. Ager, “A review of practical techniques for the diagnosis of malaria,” Annals of Tropical Medicine and Parasitology, vol. 92, no. 4, pp. 419–433, 1998. View at Publisher · View at Google Scholar · View at Scopus
  47. P. Druilhe, A. Moreno, C. Blanc, P. H. Brasseur, and P. Jacquier, “A colorimetric in vitro drug sensitivity assay for Plasmodium falciparum based on a highly sensitive double-site lactate dehydrogenase antigen-capture enzyme-linked immunosorbent assay,” American Journal of Tropical Medicine and Hygiene, vol. 64, no. 5, pp. 233–241, 2001. View at Publisher · View at Google Scholar · View at Scopus
  48. W. Peters, “The value of drug-resistant strains of Plasmodium berghei in screening for blood schizontocidal activity,” Annals of Tropical Medicine and Parasitology, vol. 69, no. 2, pp. 155–171, 1975. View at Publisher · View at Google Scholar · View at Scopus
  49. L. Bantie, S. Assefa, T. Teklehaimanot, and E. Engidawork, “In vivo antimalarial activity of the crude leaf extract and solvent fractions of Croton macrostachyus Hocsht. (Euphorbiaceae) against Plasmodium berghei in mice,” BMC Complementary and Alternative Medicine, vol. 14, article 79, 2014. View at Publisher · View at Google Scholar · View at Scopus
  50. A. O. Abosi and B. H. Raseroka, “In vivo antimalarial activity of Vernonia amygdalina,” British Journal of Biomedical Science, vol. 60, no. 2, pp. 89–91, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. A. D. Forkuo, C. Ansah, K. M. Boadu et al., “Synergistic anti-malarial action of cryptolepine and artemisinins,” Malaria Journal, vol. 15, no. 1, article no. 89, 2016. View at Publisher · View at Google Scholar · View at Scopus
  52. W. B. Dunn, N. J. C. Bailey, and H. E. Johnson, “Measuring the metabolome: current analytical technologies,” Analyst, vol. 130, no. 5, pp. 606–625, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. J. W. Allwood and R. Goodacre, “An introduction to liquid chromatography-mass spectrometry instrumentation applied in plant metabolomic analyses,” Phytochemical Analysis, vol. 21, no. 1, pp. 33–47, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. W. B. Dunn, D. Broadhurst, P. Begley et al., “Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry,” Nature Protocols, vol. 6, no. 7, pp. 1060–1083, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. H. Kanani, P. K. Chrysanthopoulos, and M. I. Klapa, “Standardizing GC-MS metabolomics,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 871, no. 2, pp. 191–201, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. G. A. Theodoridis, H. G. Gika, E. J. Want, and I. D. Wilson, “Liquid chromatography-mass spectrometry based global metabolite profiling: A review,” Analytica Chimica Acta, vol. 711, pp. 7–16, 2012. View at Publisher · View at Google Scholar · View at Scopus